• Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for musculoskeletal, breast, lung and neurologic applications.
  • Gleamer’s leadership in routine imaging, and particularly X-ray, is unparalleled through the breadth and scale of its cloud-first AI solutions.
  • DeepHealth, combined with Gleamer’s solutions will provide the industry’s most comprehensive portfolio of native clinical AI solutions and services across all core imaging modalities. 
  • Gleamer achieved an Annual Recurring Revenue (“ARR”) i compound annual growth rate exceeding 90% from 2022 through 2025 and is expected to reach approximately $30 million ARR in 2026.
  • The acquisition will augment DeepHealth’s global commercial sales force and add a strong research and development team who have developed, commercialized and delivered solutions to support over 25 clinical indications.
  • Deploying Gleamer’s solutions should drive cost efficiencies and improve patient care within RadNet by the third quarter of 2026.

RadNet, Inc. (NASDAQ: RDNT), a U.S. leader in outpatient diagnostic imaging services, has announced the acquisition of Gleamer SAS, a Paris-based radiology AI company, in a move that significantly expands its clinical AI capabilities. Gleamer will be integrated into DeepHealth, RadNet’s wholly owned digital health subsidiary, positioning the combined organization as the largest provider of radiology clinical AI solutions worldwide.

This strategic acquisition strengthens RadNet’s footprint in AI in healthcare, particularly across high-volume diagnostic imaging workflows. As imaging demand continues to surge amid a global shortage of radiologists, healthcare systems are under increasing pressure to improve efficiency, maintain diagnostic accuracy, and ensure timely patient care. By integrating Gleamer’s advanced cloud-native AI platform with DeepHealth’s growing informatics portfolio, RadNet is accelerating the evolution of intelligent, automated medical imaging.

Health Technology Insights: https://healthtechnologyinsights.com/how-smart-systems-are-transforming-clinical-workflows-in-healthcare-technology-right-now/ 

Gleamer brings a team of more than 130 professionals and serves over 700 customer contracts across 44 countries. Its multimodality AI portfolio – covering musculoskeletal, breast, lung, and neurologic imaging – includes FDA-cleared and CE-marked solutions designed to improve clinical accuracy while reducing radiologist workload. The company’s cloud-first SaaS model supports strong recurring revenue growth and high customer retention.

Howard Berger, President and CEO of RadNet, emphasized the importance of workflow automation in modern radiology. “As imaging volumes rise, reengineering high-volume workflows such as X-ray, ultrasound, and mammography is essential to sustaining access and quality of care. Automated exam prioritization and draft reporting are key to helping radiologists manage increasing demand efficiently,” he stated. The acquisition of Gleamer uniquely enhances DeepHealth’s capability to scale automated diagnostics and improve turnaround times.

By combining Gleamer’s AI-driven reporting tools with DeepHealth’s clinical AI suites spanning breast, chest, neuro, prostate, and thyroid applications, the integrated portfolio now supports screening, detection, interpretation, and follow-up across major cancer types as well as neurodegenerative and musculoskeletal conditions. With capabilities across MR, CT, X-ray, mammography, and ultrasound modalities, DeepHealth strengthens its global leadership in radiology AI solutions.

Christian Allouche, Co-Founder and CEO of Gleamer, noted that the partnership advances a shared mission of improving patient access and care quality. Meanwhile, Kees Wesdorp, President and CEO of DeepHealth, highlighted the opportunity to redefine imaging delivery through intelligence and automation at scale.

The acquisition, structured as an all-cash transaction valued at up to €230 million including milestones, reflects Gleamer’s strong recurring revenue growth, cloud-native margins, and broad regulatory approvals. RadNet plans to deploy Gleamer’s AI tools across its imaging network, particularly in high-volume X-ray workflows, enabling triage of critical findings, automated draft reporting, and measurable productivity gains.

As AI in healthcare continues transforming diagnostic medicine, RadNet’s acquisition of Gleamer signals a decisive step toward standardized, automated, and scalable radiology services that enhance efficiency while improving patient outcomes worldwide.

Health Technology Insights: https://healthtechnologyinsights.com/healthtech-top-voice-interview-with-dr-sean-kelly-chief-medical-officer-and-svp-customer-strategy-healthcare-at-imprivata/ 

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com